Determination of PD-1 expression in peripheral blood cells in patients with endometriosis
- 20 October 2020
- journal article
- research article
- Published by Taylor & Francis in Gynecological Endocrinology
- Vol. 37 (2) , 157-161
Abstract
In patients with endometriosis, ectopic endometrial tissues can escape from immune system control and survive in other tissues. The pathophysiology of endometriosis is still not fully understood. In this study, we aimed to clarify the pathophysiology of endometriosis, which is thought to be a benign but infiltrative cancer type, which has many similarities with cancer biology by determining PD-1 expression in patients with endometriosis. In this study, n = 73 cases who underwent surgery or examination at the Obstetrics and Gynecology Clinic of Sivas Cumhuriyet University Faculty of Medicine and diagnosed as endometriosis in the biopsy material taken with the pre-diagnosis of endometriosis constituted the patient group. The control group consisted of n = 64 healthy subjects without concomitant malignancy or chronic inflammatory disease. Venous whole blood samples were obtained from the study groups. PD-1 and PD-L1 levels were determined by the ELISA method from serum and plasma samples. PD-1 gene expression level was determined by RT-PCR. The PD-1 level was found to be approximately 350 +/- 150 ng/L and 45 +/- 17 ng/L in endometriosis and control group, respectively. While the PD-L1 level was approximately 760 +/- 108 ng/L in the patients, this level was 140 +/- 14 ng/L in the controls. According to the RT-PCR results, the expression of the PD-1 gene 10 times higher compared to the controls. Conclusion: The identified increase of PD-1 levels and gene expression in endometriosis groups show that immunotherapy may be used in the treatment of endometriosis.Keywords
Funding Information
- CUBAP (T-779)
This publication has 30 references indexed in Scilit:
- Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphomaBlood, 2010
- Priorities for Endometriosis Research: Recommendations From an International Consensus WorkshopReproductive Sciences, 2009
- PD-1 and Its Ligands in Tolerance and ImmunityAnnual Review of Immunology, 2008
- Endometriosis: cost estimates and methodological perspectiveHuman Reproduction Update, 2007
- The PD-1–PD-L pathway in immunological toleranceTrends in Immunology, 2006
- PD-1 Inhibits Antiviral Immunity at the Effector Phase in the LiverJournal of Experimental Medicine, 2003
- Critical Role of the Programmed Death-1 (PD-1) Pathway in Regulation of Experimental Autoimmune EncephalomyelitisJournal of Experimental Medicine, 2003
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Engagement of the Pd-1 Immunoinhibitory Receptor by a Novel B7 Family Member Leads to Negative Regulation of Lymphocyte ActivationJournal of Experimental Medicine, 2000
- EndometriosisNew England Journal of Medicine, 1993